- Home
- GH vs VRNS Comparison
GH vs VRNS Comparison
Compare GH & VRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- VRNS
- Stock Information
- Founded
- GH 2011
- VRNS 2004
- Country
- GH United States
- VRNS United States
- Employees
- GH N/A
- VRNS N/A
- Industry
- GH Medical Specialities
- VRNS Computer Software: Prepackaged Software
- Sector
- GH Health Care
- VRNS Technology
- Exchange
- GH Nasdaq
- VRNS Nasdaq
- Market Cap
- GH 4.9B
- VRNS 4.4B
- IPO Year
- GH 2018
- VRNS 2014
- Fundamental
- Price
- GH $61.40
- VRNS $59.11
- Analyst Decision
- GH Strong Buy
- VRNS Buy
- Analyst Count
- GH 16
- VRNS 16
- Target Price
- GH $57.50
- VRNS $60.31
- AVG Volume (30 Days)
- GH 3.4M
- VRNS 1.7M
- Earning Date
- GH 07-30-2025
- VRNS 07-29-2025
- Dividend Yield
- GH N/A
- VRNS N/A
- EPS Growth
- GH N/A
- VRNS N/A
- EPS
- GH N/A
- VRNS N/A
- Revenue
- GH $828,849,000.00
- VRNS $595,168,000.00
- Revenue This Year
- GH $23.36
- VRNS $14.92
- Revenue Next Year
- GH $21.43
- VRNS $16.53
- P/E Ratio
- GH N/A
- VRNS N/A
- Revenue Growth
- GH 28.74
- VRNS 14.29
- 52 Week Low
- GH $20.14
- VRNS $36.53
- 52 Week High
- GH $62.81
- VRNS $60.58
- Technical
- Relative Strength Index (RSI)
- GH 72.00
- VRNS 65.02
- Support Level
- GH $57.41
- VRNS $57.13
- Resistance Level
- GH $59.92
- VRNS $58.88
- Average True Range (ATR)
- GH 2.54
- VRNS 1.62
- MACD
- GH 0.99
- VRNS 0.14
- Stochastic Oscillator
- GH 92.69
- VRNS 93.36
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About VRNS Varonis Systems Inc.
Varonis Systems is a cybersecurity vendor focused on data privacy and security. The firm is currently undergoing a cloud transition as it weans its on-premises customers over to its cloud products that are delivered as software-as-a-service. The New York-based firm was founded in 2005 and went public in 2014.